Vaccine development gains speed with the new European Plotkin Institute for Vaccinology – News – CIVIS – Europe’s Civic University Alliance [Μετάβαση στο περιεχόμενο](#main) ![](https://civis.eu/build/assets/circle-01-CEiLnzkH.svg) ![](https://civis.eu/build/assets/circle-07-COrlhHVd.svg) ![](https://civis.eu/build/assets/circle-09-B3BMjMVU.svg) [ ![CIVIS – Europe’s Civic University Alliance](https://civis.eu/build/assets/civis-CCpvK1nT.svg)](https://civis.eu/el) - [ Ανακάλυψε ](https://civis.eu/el/discover-civis-alliance) - [ Τι είναι το CIVIS; ](https://civis.eu/el/discover-civis-alliance/what-is-civis) - [ Το έργο μας ](https://civis.eu/el/discover-civis-alliance/our-work) - [ Αποστολή, Όραμα & Αξίες ](https://civis.eu/el/discover-civis-alliance/our-institutional-journey) - [ Διακυβέρνηση & Διαχείριση ](https://civis.eu/el/discover-civis-alliance/governance-andamp-management) - [ Ποιος είναι Ποιος ](https://civis.eu/el/discover-civis-alliance/who-is-who) - [ CIVIS Association ](https://civis.eu/el/discover-civis-alliance/civis-association) [Ανοιχτά εργαστήρια & Συμμετοχή των πολιτών ](https://civis.eu/el/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Σπούδασε ](https://civis.eu/el/learn) - [ Μικτά Εντατικά προγράμματα ](https://civis.eu/el/learn/blended-intensive-programmes) - [ Ευέλικτη μάθηση ](https://civis.eu/el/learn/build-your-learning-path-with-our-modular-offer) - [ Μεταπτυχιακά προγράμματα ](https://civis.eu/el/learn/find-your-master-s-programme) - [ Εβδομάδες Κατάρτισης Προσωπικού & Παρακολούθηση Εργασίας ](https://civis.eu/el/learn/keep-on-learning-with-staff-weeks-andamp-job-shadowing) - [ Σπούδασε στο εξωτερικό ](https://civis.eu/el/learn/study-abroad-and-connect-with-civis-universities) [Discover the projects led by our students in 2025-2026 ](https://civis.eu/el/discover-civis-alliance/our-work/student-led-projects/discover-the-projects-led-by-our-students-in-2025-2026) [Μουσείο CIVIS Φόρουμ Πανεπιστημίων ](https://civis.eu/el/discover-civis-alliance/our-work/CIVIS-Museum-University-Forum) - [ Δίδαξε ](https://civis.eu/el/teach) - [ Προσκλήσεις υποβολής προτάσεων έργων ](https://civis.eu/el/teach/civis-calls) - [ Καινοτομήστε στη διδασκαλία σας ](https://civis.eu/el/teach/innovate-your-teaching) - [ Πόροι για εκπαιδευτικούς ](https://civis.eu/el/teach/resources-for-educators) [Μικτά Εντατικά Προγράμματα CIVIS: Ισχυρός Αντίκτυπος και Υψηλά Ποσοστά Ικανοποίησης, σύμφωνα με Νέα Έκθεση ](https://civis.eu/el/the-civis-newsroom/civis-bips-strong-impact-and-high-satisfaction-new-report-finds) [Musicians from all over CIVIS come together in Madrid to promote inclusiveness ](https://civis.eu/el/the-civis-newsroom/musicians-from-all-over-civis-come-together-in-madrid-to-promote-inclusiveness) - [ Κάνε έρευνα ](https://civis.eu/el/research) - [ Συνεργασία στην έρευνα ](https://civis.eu/el/research/research-collaboration) - [ Σταδιοδρομία, Δίκτυα & Κινητικότητα ](https://civis.eu/el/research/research-careers-networks-and-projects) - [ Πόροι για ερευνητές ](https://civis.eu/el/research/resources-for-researchers) [CIVIS launches new job space for early-stage researchers across Europe and Africa ](https://civis.eu/el/the-civis-newsroom/civis-launches-new-post-doc-doc-job-space-to-connect-early-stage-researchers-across-europe-and-africa) [Αντιμέτωποι με Κοινές Προκλήσεις, Διαμορφώνοντας Κοινές Λύσεις για την Αφρική και την Ευρώπη ](https://civis.eu/el/the-civis-newsroom/facing-common-challenges-shaping-joint-solutions-for-africa-and-europe) - [ Συνδέσου ](https://civis.eu/el/connect) - [ Ενημερωτικά Δελτία ](https://civis.eu/el/connect/newsletters) - [ Ημέρες CIVIS ](https://civis.eu/el/connect/civis-days) - [ Κοινωνία των Πολιτών ](https://civis.eu/el/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Επικοινωνήστε μαζί μας ](https://civis.eu/el/contact) - [ Τύπος και Επωνυμία ](https://civis.eu/el/connect/press-corner-branding-toolkit) [Ταράξτε τα νερά: Το CIVIS λανσάρει μια νέα σειρά Podcast ](https://civis.eu/el/the-civis-newsroom/make-some-waves-civis-launches-new-podcast-series) [Fake It Till You News It: Challenges and Solutions in Modern Media Student Innovation Forum ](https://civis.eu/el/discover-civis-alliance/our-work/student-led-projects/discover-the-projects-led-by-our-students-in-2025-2026/civis-creathon-contest) [ Ιστορίες ](https://civis.eu/el/the-civis-newsroom) el - [ en ](https://civis.eu/en/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ de ](https://civis.eu/de/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ fr ](https://civis.eu/fr/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ it ](https://civis.eu/it/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ es ](https://civis.eu/es/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ sv ](https://civis.eu/sv/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ ro ](https://civis.eu/ro/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) Menu - [Ανακάλυψε](https://civis.eu/el/discover-civis-alliance) [ Toggle submenu ](#primary-nav-sm-collapse-29) - [ Τι είναι το CIVIS; ](https://civis.eu/el/discover-civis-alliance/what-is-civis) - [ Το έργο μας ](https://civis.eu/el/discover-civis-alliance/our-work) - [ Αποστολή, Όραμα & Αξίες ](https://civis.eu/el/discover-civis-alliance/our-institutional-journey) - [ Διακυβέρνηση & Διαχείριση ](https://civis.eu/el/discover-civis-alliance/governance-andamp-management) - [ Ποιος είναι Ποιος ](https://civis.eu/el/discover-civis-alliance/who-is-who) - [ CIVIS Association ](https://civis.eu/el/discover-civis-alliance/civis-association) - [Σπούδασε](https://civis.eu/el/learn) [ Toggle submenu ](#primary-nav-sm-collapse-30) - [ Μικτά Εντατικά προγράμματα ](https://civis.eu/el/learn/blended-intensive-programmes) - [ Ευέλικτη μάθηση ](https://civis.eu/el/learn/build-your-learning-path-with-our-modular-offer) - [ Μεταπτυχιακά προγράμματα ](https://civis.eu/el/learn/find-your-master-s-programme) - [ Εβδομάδες Κατάρτισης Προσωπικού & Παρακολούθηση Εργασίας ](https://civis.eu/el/learn/keep-on-learning-with-staff-weeks-andamp-job-shadowing) - [ Σπούδασε στο εξωτερικό ](https://civis.eu/el/learn/study-abroad-and-connect-with-civis-universities) - [Δίδαξε](https://civis.eu/el/teach) [ Toggle submenu ](#primary-nav-sm-collapse-31) - [ Προσκλήσεις υποβολής προτάσεων έργων ](https://civis.eu/el/teach/civis-calls) - [ Καινοτομήστε στη διδασκαλία σας ](https://civis.eu/el/teach/innovate-your-teaching) - [ Πόροι για εκπαιδευτικούς ](https://civis.eu/el/teach/resources-for-educators) - [Κάνε έρευνα](https://civis.eu/el/research) [ Toggle submenu ](#primary-nav-sm-collapse-32) - [ Συνεργασία στην έρευνα ](https://civis.eu/el/research/research-collaboration) - [ Σταδιοδρομία, Δίκτυα & Κινητικότητα ](https://civis.eu/el/research/research-careers-networks-and-projects) - [ Πόροι για ερευνητές ](https://civis.eu/el/research/resources-for-researchers) - [Συνδέσου](https://civis.eu/el/connect) [ Toggle submenu ](#primary-nav-sm-collapse-33) - [ Ενημερωτικά Δελτία ](https://civis.eu/el/connect/newsletters) - [ Ημέρες CIVIS ](https://civis.eu/el/connect/civis-days) - [ Κοινωνία των Πολιτών ](https://civis.eu/el/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Επικοινωνήστε μαζί μας ](https://civis.eu/el/contact) - [ Τύπος και Επωνυμία ](https://civis.eu/el/connect/press-corner-branding-toolkit) [ Ιστορίες ](https://civis.eu/el/the-civis-newsroom) el - [ en ](https://civis.eu/en/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ de ](https://civis.eu/de/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ fr ](https://civis.eu/fr/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ it ](https://civis.eu/it/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ es ](https://civis.eu/es/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ sv ](https://civis.eu/sv/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ ro ](https://civis.eu/ro/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) 1. [The CIVIS Newsroom ](https://civis.eu/el/the-civis-newsroom) 2. Vaccine development gains speed with the new European Plotkin Institute for Vaccinology Vaccine development gains speed with the new European Plotkin Institute for Vaccinology ========================================================================================= CIVIS Highlights 8 Δεκεμβρίου 2023 Université libre de Bruxelles (ULB) inaugurated in September the European Plotkin Institute for Vaccinology, a 3,600 m2 state-of-the-art laboratory where researchers from different disciplines work together towards the same goal: to better understand, treat and prevent infectious diseases. ![](/storage/files/inauguration-de-leuropean-plotkin-institute-for-vaccinology-epiv-accelerer-le-developpement-des-vaccins-actualites-de-lulb.png) Photos: ULB The European Plotkin Institute for Vaccinology (EPIV) is a joint initiative of ULB and the University of Antwerp, supported by the Belgian federal government. At ULB, the European Plotkin Institute for Vaccinology brings together research teams in immunology and microbiology to combat infectious diseases in Belgium and around the world, and to participate in international efforts to prepare for future pandemics. It incorporates clinical research capabilities to translate the results of fundamental research into benefits for patients. Both human and material resources ---------------------------------- The Institute brings together a group of 5 research teams - and over 50 researchers already - working in the fields of immunology, bacteriology, vaccinology, virology and clinical microbiology, permanently connected to international networks to meet the challenges of current and future infectious diseases: > *In an era that demands innovation and research in healthcare, the opening of the Institute of Vaccinology next to the Brussels University Hospital represents an important combination of skills. It reinforces both our triple academic mission - combining complex care, teaching and research - and our resolute commitment to excellence and innovation. Together, we are shaping a vital ecosystem conducive to distinction, generating a strong synergy for a healthier and more resilient future in the service of our patients,* says Jean-Michel Hougardy, General Medical Director of Brussels University Hospital. The researchers have at hand a large biobank capacity for pathogens (*viruses, bacteria, parasites*) and human samples (*blood, serum, saliva, etc.*). They are studied in state-of-the-art laboratories, specially conceived for a safe handling. Also, a high-throughout testing capacity is always available and active, to help in the event of a new pandemic. Once hopes, now objectives --------------------------- The objectives of the EPIV are: - understand the precise interactions between humans and pathogens (viruses, bacteria, parasites); - identify new approaches to protecting patients from infections (vaccines, bacteriophages, new drugs); - studying in depth the immunity induced by vaccination; - identifying the specific needs of vulnerable populations to protect them more effectively against infections; - implement tools to tackle future pandemics. Considered to be the "godfather of vaccines", Stanley Plotkin - who's name was chosen for the Institute - contributed to the disappearance of rubella in the United States. He also played a major role in the development of numerous vaccines, notably against rabies, rotavirus, polio, chickenpox and cytomegalovirus. **Find out more details about EPIV by reading the [original, French story](https://actus.ulb.be/fr/presse/communiques-de-presse/recherche/inauguration-de-leuropean-plotkin-institute-for-vaccinology-epiv-accelerer-le-developpement-des-vaccins).** Related news ------------ - [ ![](https://civis.eu/storage/files/post-it-risks-800x600.jpg?token=3f32ba7f3ab0220e88eeac41defdd8bf)Innovative micro-credential for professionals on AI for the workplace launched by CIVIS Learn 10 Φεβρουαρίου 2026 ](https://civis.eu/el/the-civis-newsroom/civis-micro-credentials-ai-and-work-supporting-teams-through-change) - [ ![](https://civis.eu/storage/files/lisa-ardoin-carre-800x600.jpg?token=f714a0ebb1268db56d15373f824f5d1d)Living and working in the White Desert - vlogs from Antarctica by a ULB student CIVIS Highlights 16 Σεπτεμβρίου 2025 ](https://civis.eu/el/the-civis-newsroom/antarctica-vlogs-living-and-working-in-the-white-desert) - [ ![](https://civis.eu/storage/files/eurosud-iee-consilium-copy-800x600.jpeg?token=d7e48b887b15ee3e7750a627f84b5b8e)EUROSUD: A passport to civic-minded expertise on Southern Europe Study programmes 8 Ιουλίου 2025 ](https://civis.eu/el/the-civis-newsroom/eurosud-a-passport-to-civic-minded-expertise-on-southern-europe) [Ανακαλύψτε όλες μας τις ιστορίες](https://civis.eu/el/the-civis-newsroom) [ New fundings for the eBelong project. Sense of Belonging is now approached in the context of new HE alliances ](< https://civis.eu/el/the-civis-newsroom/ebelong-sense-of-belonging-continues >) [ Music and history welcomed first-year students at NKUA ](< https://civis.eu/el/the-civis-newsroom/first-year-students-at-nkua-welcomed-with-a-one-off-musical-celebration-for-the-first-time-in-history >) ![CIVIS – Europe’s Civic University Alliance](https://civis.eu/build/assets/civis-CCpvK1nT.svg) ------------------------------------------------------------------------------------------------- Europe’s Civic University Alliance ![Co-funded by the European Union](https://civis.eu/build/assets/co-funded-by-the-european-union-DSKLW1us.png)Views and opinions expressed do not necessarily reflect those of the European Union or the European Education and Culture Executive Agency (EACEA). Neither can be held responsible for them. ### Άνθρωποι - [ Φοιτητές-/τριες ](https://civis.eu/el/i-am-a-student) - [ Ακαδημαϊκοί και ερευνητές ](https://civis.eu/el/i-am-an-academic-researcher) - [ Διοικητικοί ](https://civis.eu/el/i-am-an-administrator) - [ Κοινωνία των πολιτών ](https://civis.eu/el/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Τύπος ](https://civis.eu/el/connect/press-corner-branding-toolkit) ### Χρήσιμοι σύνδεσμοι - [ Πόροι ](https://civis.eu/el/resources) - [ Πλατφόρμα CIVIS Agora ](https://civis.eu/el/civis-agora-the-operational-hub-of-the-civis-digital-campus) - [ Πρωτοβουλία των Ευρωπαϊκών Πανεπιστημίων ](https://civis.eu/el/european-universities-initiative) - [ Προηγούμενες εκδηλώσεις ](https://civis.eu/el/past-events) - [ Επικοινωνία ](https://civis.eu/el/contact) [Newsletters](https://civis.eu/el/connect/newsletters) ### Social networks - [ ![](https://civis.eu/storage/files/instagram.svg) Instagram ](https://www.instagram.com/civis.eu/) - [ ![](https://civis.eu/storage/files/linkedin.svg) LinkedIn ](https://www.linkedin.com/company/civis-eu) - [ ![](https://civis.eu/storage/files/facebook.svg) Facebook ](https://www.facebook.com/CIVISEuropeanUniversity/) - [ ![](https://civis.eu/storage/files/youtube.svg) YouTube ](https://www.youtube.com/channel/UCdCm0FfreX81BuNH-znlRGQ) © 2026 – CIVIS – All rights reserved - [ Cookie Policy ](https://civis.eu/el/cookie-policy) - [ Privacy policy ](https://civis.eu/el/privacy-policy) Website by [Typi Design](https://typi.be) • Design by [Atelier Milky](https://ateliermilky.com) [ ](#top) Search